Результаты поиска - G. Stoter

Отмена результатов
  1. 1
    Stenting in malignant vena caval obstruction

    Stenting in malignant vena caval obstruction по Matthijs Oudkerk, F. M. J. Heystraten, G. Stoter

    Опубликовано 1993
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  2. 2
    Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development

    Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development по CJH Gerrits, M. de Jonge, JHM Schellens, G. Stoter, Jaap Verweij

    Опубликовано 1997
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  3. 3
    Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines

    Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines по Henry Burger, Kees Nooter, AWM Boersma, Christine J. Kortland, G. Stoter

    Опубликовано 1998
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    Lack of correlation between cisplatin-induced apoptosis,p53 status and expression of Bcl-2 family proteins in testicular germ cell tumour cell lines

    Lack of correlation between cisplatin-induced apoptosis,p53 status and expression of Bcl-2 family proteins in testicular germ cell tumour cell lines по Herman Burger, Kees Nooter, Antonius W.M. Boersma, Christine J. Kortland, G. Stoter

    Опубликовано 1997
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR.

    Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR... по R J van de Griend, R. L. H. Bolhuis, G. Stoter, Robert C. Roozemond

    Опубликовано 1987
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detection

    Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detection по Peter de Bruijn, Jaap Verweij, Walter J. Loos, Kees Nooter, G. Stoter, Alex Sparreboom

    Опубликовано 1997
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  7. 7
    Effective cross-over to granisetron after failure to ondansetron, a randomized double blind study in patients failing ondansetron plus dexamethasone during the first 24 hours following highly emetogenic chemotherapy

    Effective cross-over to granisetron after failure to ondansetron, a randomized double blind study in patients failing ondansetron plus dexamethasone during the first 24 hours follo... по Ronald de Wit, A C de Boer, Gabriele Linden, G. Stoter, Alex Sparreboom, Jaap Verweij

    Опубликовано 2001
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  8. 8
    Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients

    Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients по Ronald de Wit, WHJ Kruit, G. Stoter, Maaike de Boer, Joseph Kerger, Jaco J. Verweij

    Опубликовано 1998
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  9. 9
    Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere)

    Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere) по P.H.E. Hilkens, Jaap Verweij, C. J. Vecht, G. Stoter, Martin J. van den Bent

    Опубликовано 1997
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  10. 10
    Impact of Body-Size Measures on Irinotecan Clearance: Alternative Dosing Recommendations

    Impact of Body-Size Measures on Irinotecan Clearance: Alternative Dosing Recommendations по Ron H.J. Mathijssen, Jaap Verweij, Maja J.A. de Jonge, Kees Nooter, G. Stoter, Alex Sparreboom

    Опубликовано 2002
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  11. 11
    A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance

    A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance по Jaap Verweij, Hans Herweijer, R. Oosterom, MEL van der Burg, A.S.T. Planting, Caroline Seynaeve, G. Stoter, Kees Nooter

    Опубликовано 1991
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  12. 12
    Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists

    Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists по M de Boer-Dennert, Ronald de Wit, PIM Schmitz, J. Djontono, V van Beurden, G. Stoter, Jaap Verweij

    Опубликовано 1997
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  13. 13
    Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump

    Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump по Herman Burger, Hans van Tol, Antonius W.M. Boersma, Mariël Brok, Erik A.C. Wiemer, G. Stoter, Kees Nooter

    Опубликовано 2004
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  14. 14
    Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study

    Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study по SH Goey, A.M.M. Eggermont, CJA Punt, Rob Slingerland, JW Gratama, R. Oosterom, R. Oskam, RLH Bolhuis, G. Stoter

    Опубликовано 1995
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  15. 15
    Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group

    Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Coop... по Ronald de Wit, G. Stoter, DTh Sleijfer, J.P. Neijt, W.W. ten Bokkel Huinink, Linda de Prijck, Laurence Collette, Richard Sylvester

    Опубликовано 1998
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  16. 16
    COMBINATION CHEMOTHERAPY WITH CIS-DIAMMINE-DICHLORO-PLATINUM, VINBLASTINE, AND BLEOMYCIN IN ADVANCED TESTICULAR NON-SEMINOMA

    COMBINATION CHEMOTHERAPY WITH CIS-DIAMMINE-DICHLORO-PLATINUM, VINBLASTINE, AND BLEOMYCIN IN ADVANCED TESTICULAR NON-SEMINOMA по G. Stoter, D.Th. Sleijfer, C. P. J. Vendrik, H. Schraffordt Koops, A Struyvenberg, A.T. van Oosterom, Th. M. Brouwers, Herbert M. Pinedo

    Опубликовано 1979
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  17. 17
    Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours

    Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours по JHM Schellens, Jun Ma, A.S.T. Planting, MEL van der Burg, E. van Meerten, M de Boer-Dennert, PIM Schmitz, G. Stoter, Jaap Verweij

    Опубликовано 1996
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  18. 18
    Weekly cisplatin and daily oral etoposide is highly effective in platinum pretreated ovarian cancer

    Weekly cisplatin and daily oral etoposide is highly effective in platinum pretreated ovarian cancer по M.E.L. van der Burg, Ronald de Wit, Wim L.J. van Putten, A. Logmans, Wim H.J. Kruit, G. Stoter, Jaap Verweij

    Опубликовано 2002
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  19. 19
    Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group

    Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tra... по R. de Wit, G. Stoter, Dirk Th. Sleijfer, Stuart Kaye, PHM de Mulder, W. ten Bokkel Huinink, P Spaander, M de Pauw, Richard Sylvester

    Опубликовано 1995
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  20. 20
    Treatment of Metastatic Renal Cell Carcinoma With Autologous T-Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX: First Clinical Experience

    Treatment of Metastatic Renal Cell Carcinoma With Autologous T-Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX: First Clinical Experience по C. B. H. W. Lamers, Stefan Sleijfer, Arnold G. Vulto, Wim H.J. Kruit, Mike Kliffen, Reno Debets, Jan W. Gratama, G. Stoter, Egbert Oosterwijk

    Опубликовано 2006
    Полный текст Полный текст
    Carta
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: